Pharma Stock to Watch Out Today; Expects EBITDA Margin of 23%

Shares of Lupin are in focus today as the management expects the company to reach an EBITA margin between 22.5% to 23.5% for FY25.

Share price

The share price of Lupin Limited soared by 1.61% at ₹2088.65 apiece, compared to its previous day’s closing of ₹2055.65. The market capitalisation is valued at ₹95,632.77 crore.

Financial performance

Revenue from operations soared by 10.9% YoY from ₹5,197.4 crores in Q3FY24 to ₹5,767.7 crores in Q3FY25, while net profit was up by 38% YoY to ₹858.8 crore against year-ago period of ₹618.7 crore.

About the company

With a global presence in over 100 countries, Lupin is a leading pharmaceutical leader involved in the manufacturing of generic and branded medicines, as well as Active Pharmaceutical Ingredients (APIs).